Announced Mon, 16 Mar · 17:42 IST

Intimation On Investor Meeting under reg 30 of SEBI (LODR) Reg, 2015 on 18th March, 2026.

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹1628.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5+1.4+2.1+3.4+2.3+3.7+11.8+13.6+45.6+60.6
Up moveDown movePending
AI summary

Fredun Pharmaceuticals has informed the stock exchange that its management will meet a group of investors in Mumbai on 18th March 2026. The meeting is being organized by Share India Securities Limited. The agenda is to discuss the company's business overview and financial performance as part of its ongoing investor engagement activities. The intimation was filed under SEBI's Listing Obligations and Disclosure Requirements (Reg 30) and signed by Managing Director Fredun Nariman Medhora. No specific financial numbers or material announcements were disclosed in this filing — it is purely a notice of an upcoming meeting.

Likely market impact

This is a routine investor engagement intimation and is unlikely to have a direct impact on the stock price. However, it signals that the company is actively engaging with the investor community, which can support visibility and interest in the stock.